APOE and Alzheimer disease: Furthermore, an APOE R136S mutation (APOE Christchurch, APOEch) which has protective effect against AD development could downregulate APOE binding to LDLR reducing lipid burden which might explain the mechanism of clinical benefits of APOEch mutation 76.